Isracann announces to enter into MoU for European distribution
Category: #business  By Mateen Dalal  Date: 2020-01-02
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Isracann announces to enter into MoU for European distribution

Isracann Biosciences, Inc., an Israel-based specialty pharmaceutical company, announced that it has entered into a Memorandum of Understanding (MoU) for a distribution agreement to serve major legalized cannabis markets in Europe. The name of partner distributor has not been disclosed yet.

The anonymous distributor has conditionally entered into an MoU with Isracann due to commercial realism. As a part of the agreement, the distributor will help the company towards strategic export and leveraging opportunities. The principal proposal of the agreement is to offer a non-binding alternative on dried flower products depending upon export laws in Israel and minimum quantity, quality, and time of delivery.

The proposed distributor signifies that both the partners will import the product through the Republic of Malta, in accordance with jurisdictional transshipment and importation regulations. The distributor affirms its plan to use the product of Isracann as raw input for value-added handling, extraction, packing, branding, and export distribution.

Under the agreement, the unnamed distributor will build a regional processing facility to satisfy European Union Good Manufacturing Practice (EU-GMP). The EU has specified these standards to implement them as a regulatory need for medicinal products.

Darryl Jones, CEO, Isracann, reportedly stated that the company realized that it has a requirement for strategic distribution agreements before beginning its agriculture endeavor in Israel. The company selected Malta owing to its positive business environment, outstanding logistics, and proximity to key European markets, he further added.

Isracann had earlier declared Germany as its target to enter into the EU markets, which is pending due to Israeli export licensing approval. In March 2017, Germany had legalized medical cannabis and has emerged as the major medical cannabis market in Europe. The country is likely to grow considerably over the next years due to the presence of a potential patient base of more than 1 million.
 

Source links:

https://www.globenewswire.com/news-release/2020/01/02/1965510/0/en/Isracann-Enters-MOU-for-European-Distribution.html

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal     twitter

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More..

More News By Mateen Dalal

Xiaomi and Oppo team up with UNISOC to manufacture in-house 5G chipsets

Xiaomi and Oppo team up with UNISOC to manufacture in-house 5G chipsets

By Mateen Dalal

The two companies intend to introduce their custom-made sub-6GHz 5G chipsets by the end of 2021. UNISOC has managed to raise around USD 817.20 million for its new venture. Chinese electronics giants including Xiaomi Corp. and Guangdong Oppo Mob...

Twitter explored USD 4 billion takeover of audio-chat app Clubhouse

Twitter explored USD 4 billion takeover of audio-chat app Clubhouse

By Mateen Dalal

Twitter, an American microblogging service company, had touted plans of acquiring Clubhouse, an audio chat iPhone app and live drop-in audio networking platform. The deal was estimated to be valued at around USD 4 billion, as per reliable sources. T...

Beyond Meat sets up factory in China to expedite localized innovation

Beyond Meat sets up factory in China to expedite localized innovation

By Mateen Dalal

American plant-based meat substitute producer Beyond Meat has opened a new production facility in China. Apparently, this recent setup is the company’s first facility outside the U.S., making it the only multinational organization solely focusi...